Methenamine hippurate adverse reactions

Revision as of 15:02, 9 January 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Methenamine hippurate}} {{CMG}}; {{AE}} {{AK}} ==ADVERSE REACTIONS== Minor adverse reactions have been reported in less than 3.5% of patients treated. These reac...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Methenamine hippurate
HIPREX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


ADVERSE REACTIONS

Minor adverse reactions have been reported in less than 3.5% of patients treated. These reactions have included nausea, upset stomach, dysuria, and rash.



References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/17681s014lbl.pdf